Sheree Rye

2.7k total citations · 1 hit paper
18 papers, 2.0k citations indexed

About

Sheree Rye is a scholar working on Oncology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Sheree Rye has authored 18 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 3 papers in Dermatology. Recurrent topics in Sheree Rye's work include Cancer survivorship and care (12 papers), Lymphatic System and Diseases (10 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Sheree Rye is often cited by papers focused on Cancer survivorship and care (12 papers), Lymphatic System and Diseases (10 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Sheree Rye collaborates with scholars based in Australia, United Kingdom and United States. Sheree Rye's co-authors include Sandra C. Hayes, Tracey DiSipio, Beth Newman, Diana Battistutta, Christobel Saunders, Christopher Pyke, John Bashford, Rebecca M. Speck, Kathryn H. Schmitz and Elizabeth Eakin and has published in prestigious journals such as Cancer, Cancer Research and The Lancet Oncology.

In The Last Decade

Sheree Rye

16 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis

2013 1.3k citations Tracey DiSipio, Sheree Rye et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Sheree Rye

Since Specialization

Citations

This map shows the geographic impact of Sheree Rye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheree Rye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheree Rye more than expected).

Fields of papers citing papers by Sheree Rye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheree Rye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheree Rye. The network helps show where Sheree Rye may publish in the future.

Co-authorship network of co-authors of Sheree Rye

This figure shows the co-authorship network connecting the top 25 collaborators of Sheree Rye. A scholar is included among the top collaborators of Sheree Rye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheree Rye. Sheree Rye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Mild symptoms matter: Results from a prospective, longitudinal study on the relationship between symptoms, lymphedema and health-related outcomes post-gynecological cancer 2024 ·Gynecologic Oncology ·Melanie L. Plinsinga, Sheree Rye, Tamara L. Jones, Dimitrios Vagenas, Leigh C. Ward, Monika Janda, Andreas Obermair, Sandra C. Hayes	0
2	Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocol 2024 ·BMJ Open ·Sandra C. Hayes, Rosalind R. Spence, Monika Janda, Elizabeth Eakin, Catherine Shannon, Jeffrey C. Goh, Vanessa L. Beesley, Dimitrios Vagenas, Penelope M. Webb, Jermaine Coward, Louisa G. Gordon, (unknown), (unknown), Sheree Rye, (unknown), (unknown), Marcelo Nascimento, James Nicklin, (unknown), Andreas Obermair	0
3	Is Vitamin D Level at Melanoma Diagnosis Associated With Stage Of Tumor? An Observational Study of Melanoma Patients Living in a High Ultraviolet Radiation Environment 2019 ·Military Medicine ·Michael G. Kimlin, Pip Youl, Peter D. Baade, Sheree Rye, A. Brodie	1
4	Weight and weight change following breast cancer: evidence from a prospective, population-based, breast cancer cohort study 2015 ·BMC Cancer ·Dimitrios Vagenas, Tracey DiSipio, Diana Battistutta, Wendy Demark‐Wahnefried, Sheree Rye, John Bashford, Christopher Pyke, Christobel Saunders, Sandra C. Hayes	54
5	Changes in Outdoor Workers' Sun-Related Attitudes, Beliefs, and Behaviors 2014 ·Journal of Occupational and Environmental Medicine ·Sheree Rye, Monika Janda, Melissa Stoneham, (unknown), Marguerite C. Sendall, Philippa Youl, Thomas Tenkate, (unknown), (unknown), (unknown), Michael G. Kimlin	22
6	Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis breakdown → 2013 ·The Lancet Oncology ·Tracey DiSipio, Sheree Rye, Beth Newman, Sandra C. Hayes	1318
7	Prevalence of breast cancer treatment sequelae over 6 years of follow‐up 2012 ·Cancer ·Kathryn H. Schmitz, Rebecca M. Speck, Sheree Rye, Tracey DiSipio, Sandra C. Hayes	2
8	Exercise for health: a randomized, controlled trial evaluating the impact of a pragmatic, translational exercise intervention on the quality of life, function and treatment-related side effects following breast cancer 2012 ·Breast Cancer Research and Treatment ·Sandra C. Hayes, Sheree Rye, Tracey DiSipio, Patsy Yates, John Bashford, Christopher Pyke, Christobel Saunders, Diana Battistutta, Elizabeth Eakin	149
9	Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the Pulling Through Study. 2012 ·PubMed ·Kathryn H. Schmitz, Rebecca M. Speck, Sheree Rye, Tracey DiSipio, Sandra C. Hayes	132
10	Prevalence and prognostic significance of secondary lymphedema following breast cancer 2011 ·UWA Profiles and Research Repository (University of Western Australia) ·Sandra C. Hayes, Tracey DiSipio, Sheree Rye, J. Alejandro López, Christobel Saunders, Christopher Pyke, John Bashford, Diana Battistutta, Beth Newman	1
11	Prevalence and Prognostic Significance of Secondary Lymphedema Following Breast Cancer 2011 ·Lymphatic Research and Biology ·Sandra C. Hayes, (unknown), Sheree Rye, J. Alejandro López, Christobel Saunders, Christopher Pyke, John Bashford, Diana Battistutta, Beth Newman	72
12	Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphoedema 2010 ·Faculty of Health; Institute of Health and Biomedical Innovation ·Sandra C. Hayes, Sheree Rye, Diana Battistutta, Beth Newman	3
13	Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life 2010 ·Health and Quality of Life Outcomes ·Sandra C. Hayes, Sheree Rye, Diana Battistutta, Tracey DiSipio, Beth Newman	107
14	Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema. 2010 ·PubMed ·Sandra C. Hayes, Sheree Rye, Diana Battistutta, Beth Newman	45
15	Abstract PD08-08: Exercise for Health: A Randomised, Controlled Trial of an Exercise Intervention for Women with Breast Cancer — Effect on Upper-Body Function 2010 ·Cancer Research ·Sandra C. Hayes, Sheree Rye, Elizabeth Eakin, Diana Battistutta	2
16	Exercise for health : a breast cancer recovery program - quality of life benefits [Conference Abstract] 2009 ·QUT ePrints (Queensland University of Technology) ·(unknown), Sheree Rye, (unknown), (unknown), Kym Spathonis, Elizabeth Eakin, Sandra C. Hayes	1
17	Three-day and one-day chemotherapy for urinary tract infections in general practice 1981 ·Journal of Antimicrobial Chemotherapy ·Clive Charlton, (unknown), (unknown), (unknown), (unknown), (unknown), Sheree Rye, Jane Valentine, D G White	13
18	Three-day and ten-day chemotherapy for urinary tract infections in general practice. 1976 ·BMJ ·Clive Charlton, (unknown), (unknown), (unknown), (unknown), (unknown), Sheree Rye	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact